Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
Virus Research|June 19, 2007
Comparative genetic analysis of genomic DNA sequences of two human isolates of Tanapox virusSteven H Nazarian, John W Barrett, A Michael Frace, et al.
International Journal of Endocrinology|September 3, 2021
Detection of Circulating Tumor DNA in Patients with Thyroid NodulesKrupal B Patel, Nicholas Cormier, James Fowler, et al.
JAMA Otolaryngology-- Head & Neck Surgery|June 22, 2013
High frequency of activating PIK3CA mutations in human papillomavirus-positive oropharyngeal cancerAnthony C Nichols, David A Palma, Winsion Chow, et al.
Head & Neck|December 15, 2023
A comparison of timing and patterns of treatment failure, and survival outcomes after progression between HPV+ and HPV- patients undergoing chemoradiation for oropharyngeal squamous cell carcinomasFrancisco Laxague, Peter Y F Zeng, Dorsa Zabihi, et al.
International Journal of Cancer|November 24, 2018
A controlled trial of HNSCC patient-derived xenografts reveals broad efficacy of PI3Kα inhibition in controlling tumor growthKara M Ruicci, Jalna Meens, Ren X Sun, et al.
Molecular Oncology|August 9, 2019
Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibitionKara M Ruicci, Paul Plantinga, Nicole Pinto, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 16, 2020
TAM family receptors in conjunction with MAPK signalling are involved in acquired resistance to PI3Kα inhibition in head and neck squamous cell carcinomaKara M Ruicci, Jalna Meens, Paul Plantinga, et al.
Oral Oncology|April 16, 2025
Molecular features of T and N stage progression in laryngeal cancerNicholas Li, Peter Y F Zeng, Hugh A J Kim, et al.
International Journal of Otolaryngology|April 7, 2021
Does HPV Subtype Predict Outcomes in Head and Neck Cancers?Hedyeh Ziai, Andrew Warner, Neil Mundi, et al.
Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale|February 23, 2022
Introduction and expression of PIK3CAE545K in a papillary thyroid cancer BRAFV600E cell line leads to a dedifferentiated aggressive phenotypeNicole Pinto, Kara M Ruicci, Mohammed Imran Khan, et al.
Pageof 12